Table 5 Age-matched model comparing survival between cohorts in 64 age-matched patient couples
From: Pirfenidone improves survival in IPF: results from a real-life study
HR | 95% CI | P value | |
|---|---|---|---|
Centre | 0.27 | 0.14, 0.55 | P < 0.0001 |
Gender | 1.96 | 0.99, 3.88 | P < 0.053 |
Age | 1.00 | 0.96, 1.04 | P < 0.838 |
FVC | 0.98 | 0.97, 1.00 | P < 0.204 |